Cleared Traditional

K140473 - DUALGUARD

K140473 is an FDA 510(k) clearance for DUALGUARD, manufactured by Flexicare Medical, Ltd.. The device is a Class 2 Anesthesiology device with product code CCK cleared through the Traditional 510(k) pathway after a 44-day FDA review.

K140473 · Flexicare Medical, Ltd. · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2014
Decision
44d
Days
Class 2
Risk

K140473 is an FDA 510(k) clearance for the DUALGUARD. Classified as Analyzer, Gas, Carbon-dioxide, Gaseous-phase (product code CCK), Class II - Special Controls.

Submitted by Flexicare Medical, Ltd. (Mid Glamorgan, GB). The FDA issued a Cleared decision on April 10, 2014 after a review of 44 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.1400 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Flexicare Medical, Ltd. devices

FDA 510(k) Submission Details - K140473

510(k) Number K140473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 25, 2014
Decision Date April 10, 2014
Days to Decision 44 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Regulatory Context
Review time vs. panel average
96d faster than avg
Panel avg: 140d · This submission: 44d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

CCK Device Classification - Class 2, Special Controls

Product Code CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.1400
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CCK Analyzer, Gas, Carbon-dioxide, Gaseous-phase

All 180
Devices cleared under the same product code (CCK) and FDA review panel - the closest regulatory comparables to K140473.
SOFTECH Plus ETCO2 Cannula
K143469 · Teleflexmedical, Inc. · Feb 2015
CAPNOSTREAM20P WITH HIFI C02 MONITORING
K123690 · Oridion Medical 1987 , Ltd. · Aug 2014
SOFTECH PLUS ETC02 CANNULA
K132946 · Teleflexmedical, Inc. · Jun 2014
MICROSTREAM FILTERLINE ICU
K121927 · Oridion Medical 1987 , Ltd. · Nov 2012
CAPNOSTREAM20P WITH AI/ODI
K112368 · Oridion Medical 1987 , Ltd. · Jul 2012
END TIDAL CO2 NASAL CANNULA
K120518 · Care Fusion · May 2012